{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:10:53Z","timestamp":1649193053217},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00347-010-2187-7","type":"journal-article","created":{"date-parts":[[2011,5,16]],"date-time":"2011-05-16T15:25:41Z","timestamp":1305559541000},"page":"425-431","source":"Crossref","is-referenced-by-count":0,"title":["Medikament\u00f6se Therapie und Strahlentherapie bei endokriner Orbitopathie"],"prefix":"10.1007","volume":"108","author":[{"given":"F.","family":"Beisse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Lagr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,15]]},"reference":[{"key":"2187_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson A et al (2008) Consensus statement of the European Group on Graves\u2018 Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158(3):273\u2013285","journal-title":"Eur J Endocrinol"},{"key":"2187_CR2","first-page":"145","volume":"Endocrinol","author":"Terwee","year":"2005","unstructured":"Terwee CB, Prummel MF, Gerding MN et al (2005) Measuring disease activity to predict therapeutic outcome in Graves\u2018 ophthalmopathy. Clin Endocrinol (Oxf) 62(2):145\u2013155","journal-title":"Clin"},{"key":"2187_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.1997.7.885","volume":"7","author":"Gerding","year":"1997","unstructured":"Gerding MN, Terwee CB, Dekker FW et al (1997) Quality of life in patients with Graves\u2018 ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7(6):885\u2013889","journal-title":"Thyroid"},{"key":"2187_CR4","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","volume":"90","author":"Kahaly","year":"2005","unstructured":"Kahaly GJ, Pitz S, Hommel G, Dittmar M (2005) Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves\u2018 orbitopathy. J Clin Endocrinol Metab 90(9):5234\u20135240","journal-title":"J Clin Endocrinol Metab"},{"key":"2187_CR5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","volume":"88","author":"Ebner","year":"2004","unstructured":"Ebner R, Devoto MH, Weil D et al (2004) Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 88(11):1380\u20131386","journal-title":"Br J Ophthalmol"},{"key":"2187_CR6","unstructured":"Kahaly G (2007) Management of moderately severe Graves\u2018 orbitopathy In: Wiersinga WM, Kahaly G (Hrsg) Graves\u2018 orbitopathy: a multidisciplinary approach. Karger, Basel, S 120\u2013152"},{"key":"2187_CR7","first-page":"323","volume":"Endocrinol","author":"Wakelkamp","year":"2005","unstructured":"Wakelkamp IM, Baldeschi L, Saeed P et al (2005) Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves\u2018 ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf) 63(3):323\u2013328","journal-title":"Clin"},{"key":"2187_CR8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","volume":"129","author":"Bartalena","year":"1998","unstructured":"Bartalena L, Marcocci C, Tanda ML et al (1998) Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129(8):632\u2013635","journal-title":"Ann Intern Med"},{"key":"2187_CR9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","volume":"326","author":"Tallstedt","year":"1992","unstructured":"Tallstedt L, Lundell G, Torring O et al (1992) Occurrence of ophthalmopathy after treatment for Graves\u2018 hyperthyroidism. The Thyroid Study Group. N Engl J Med 326(26):1733\u20131738","journal-title":"N Engl J Med"},{"key":"2187_CR10","unstructured":"Karow T, Lang-Roth R (2010) Allgemeine und spezielle Pharmakologie und Toxikologie, 18 Aufl., K\u00f6ln"},{"key":"2187_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","volume":"17","author":"Le","year":"2007","unstructured":"Le Moli R, Baldeschi L, Saeed P et al (2007) Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves\u2018 ophthalmopathy. Thyroid 17(4):357\u2013362","journal-title":"Thyroid"},{"key":"2187_CR12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","volume":"321","author":"Prummel","year":"1989","unstructured":"Prummel MF, Mourits MP, Berghout A et al (1989) Prednisone and cyclosporine in the treatment of severe Graves\u2018 ophthalmopathy. N Engl J Med 321(20):1353\u20131359","journal-title":"N Engl J Med"},{"key":"2187_CR13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2362.1986.tb01016.x","volume":"16","author":"Kahaly","year":"1986","unstructured":"Kahaly G, Schrezenmeir J, Krause U et al (1986) Ciclosporin and prednisone v. prednisone in treatment of Graves\u2018 ophthalmopathy: a controlled, randomized and prospective study. Eur J Clin Invest 16(5):415\u2013422","journal-title":"Eur J Clin Invest"},{"key":"2187_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2249.1996.d01-854.x","volume":"106","author":"Kahaly","year":"1996","unstructured":"Kahaly G, Pitz S, Muller-Forell W, Hommel G (1996) Randomized trial of intravenous immunoglobulins versus prednisolone in Graves\u2018 ophthalmopathy. Clin Exp Immunol 106(2):197\u2013202","journal-title":"Clin Exp Immunol"},{"key":"2187_CR15","first-page":"13","volume":"Endocrinol","author":"Antonelli","year":"1992","unstructured":"Antonelli A, Saracino A, Alberti B et al (1992) High-dose intravenous immunoglobulin treatment in Graves\u2018 ophthalmopathy. Acta Endocrinol (Copenh) 126(1):13\u201323","journal-title":"Acta"},{"key":"2187_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/thy.1997.7.579","volume":"7","author":"Baschieri","year":"1997","unstructured":"Baschieri L, Antonelli A, Nardi S et al (1997) Intravenous immunoglobulin versus corticosteroid in treatment of Graves\u2018 ophthalmopathy. Thyroid 7(4):579\u2013585","journal-title":"Thyroid"},{"key":"2187_CR17","doi-asserted-by":"crossref","unstructured":"Paridaens D, Bosch WA van den, Loos TL van der et al (2005) The effect of etanercept on Graves\u2018 ophthalmopathy: a pilot study. Eye (Lond) 19(12):1286\u20131289","DOI":"10.1038\/sj.eye.6701768"},{"key":"2187_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","volume":"156","author":"Salvi","year":"2007","unstructured":"Salvi M, Vannucchi G, Campi I et al (2007) Treatment of Graves\u2018 disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol 156(1):33\u201340","journal-title":"Eur J Endocrinol"},{"key":"2187_CR19","first-page":"8","volume":"Endocrinol","author":"Perros","year":"1990","unstructured":"Perros P, Weightman DR, Crombie AL, Kendall-Taylor P (1990) Azathioprine in the treatment of thyroid-associated ophthalmopathy. Acta Endocrinol (Copenh) 122(1):8\u201312","journal-title":"Acta"},{"key":"2187_CR20","first-page":"13","volume":"Endocrinol","author":"Kahaly","year":"1990","unstructured":"Kahaly G, Lieb W, Muller-Forell W et al (1990) Ciamexone in endocrine orbitopathy. A randomized double-blind, placebo-controlled study. Acta Endocrinol (Copenh) 122(1):13\u201321","journal-title":"Acta"},{"key":"2187_CR21","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1210\/jc.2004-0697","volume":"89","author":"Dickinson","year":"2004","unstructured":"Dickinson AJ, Vaidya B, Miller M et al (2004) Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 89(12):5910\u20135915","journal-title":"J Clin Endocrinol Metab"},{"key":"2187_CR22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(02)01041-2","volume":"109","author":"Uddin","year":"2002","unstructured":"Uddin JM, Davies PD (2002) Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 109(6):1183\u20131187","journal-title":"Ophthalmology"},{"key":"2187_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00347-007-1592-z","volume":"104","author":"Wabbels","year":"2007","unstructured":"Wabbels B, Forl M (2007) Botulinum toxin treatment for crocodile tears, spastic entropion and for dysthyroid upper eyelid retraction. Ophthalmologe 104(9):771\u2013776","journal-title":"Ophthalmologe"},{"key":"2187_CR24","doi-asserted-by":"crossref","unstructured":"Adams GG, Kirkness CM, Lee JP (1987) Botulinum toxin A induced protective ptosis. Eye (Lond) 1(Pt 5):603\u2013608","DOI":"10.1038\/eye.1987.93"},{"key":"2187_CR25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/bjo.82.7.754","volume":"82","author":"Kalmann","year":"1998","unstructured":"Kalmann R, Mourits MP (1998) Prevalence and management of elevated intraocular pressure in patients with Graves\u2018 orbitopathy. Br J Ophthalmol 82(7):754\u2013757","journal-title":"Br J Ophthalmol"},{"key":"2187_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2007.04.008","volume":"83","author":"Leer","year":"2007","unstructured":"Leer JW, Houtte P van, Seegenschmiedt H (2007) Radiotherapy of non-malignant disorders: Where do we stand? Radiother Oncol 83(2):175\u2013177","journal-title":"Radiother Oncol"},{"key":"2187_CR27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(00)02165-6","volume":"355","author":"Mourits","year":"2000","unstructured":"Mourits MP, Kempen-Harteveld ML van, Garcia MB et al (2000) Radiotherapy for Graves\u2018 orbitopathy: randomised placebo-controlled study. Lancet 355(9214):1505\u20131509","journal-title":"Lancet"},{"key":"2187_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/jc.2003-030809","volume":"89","author":"Prummel","year":"2004","unstructured":"Prummel MF, Terwee CB, Gerding MN et al (2004) A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves\u2018 ophthalmopathy. J Clin Endocrinol Metab 89(1):15\u201320","journal-title":"J Clin Endocrinol Metab"},{"key":"2187_CR29","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0161-6420(01)00632-7","volume":"108","author":"Gorman","year":"2001","unstructured":"Gorman CA, Garrity JA, Fatourechi V et al (2001) A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves\u2018 ophthalmopathy. Ophthalmology 108(9):1523\u20131534","journal-title":"Ophthalmology"},{"key":"2187_CR30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0140-6736(93)92001-A","volume":"342","author":"Prummel","year":"1993","unstructured":"Prummel MF, Mourits MP, Blank L et al (1993) Randomized double-blind trial of prednisone versus radiotherapy in Graves\u2018 ophthalmopathy. Lancet 342(8877):949\u2013954","journal-title":"Lancet"},{"key":"2187_CR31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","volume":"56","author":"Bartalena","year":"1983","unstructured":"Bartalena L, Marcocci C, Chiovato L et al (1983) Orbital cobalt irradiation combined with systemic corticosteroids for Graves\u2018 ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 56(6):1139\u20131144","journal-title":"J Clin Endocrinol Metab"},{"key":"2187_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1128141","volume":"41","author":"Sterker","year":"2009","unstructured":"Sterker I, Tegetmeyer H, Papsdorf K, Fuhrer-Sakel D (2009) Effect of combined intravenous glucocorticoids and orbital radiotherapy in restoring driving competency in patients with Graves\u2018 orbitopathy. Horm Metab Res 41(5):391\u2013396","journal-title":"Horm Metab Res"},{"key":"2187_CR33","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2003.12.054","volume":"111","author":"Wakelkamp","year":"2004","unstructured":"Wakelkamp IM, Tan H, Saeed P et al (2004) Orbital irradiation for Graves\u2018 ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 111(8):1557\u20131562","journal-title":"Ophthalmology"},{"key":"2187_CR34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)03795-1","volume":"55","author":"Gerling","year":"2003","unstructured":"Gerling J, Kommerell G, Henne K et al (2003) Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16\u00a0Gy. Int J Radiat Oncol Biol Phys 55(1):182\u2013189","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2187-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-010-2187-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-010-2187-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:32:33Z","timestamp":1560198753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-010-2187-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1007\/s00347-010-2187-7","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}